|
BAKER & MCKENZIE

Profile to come
PricewaterhouseCoopers

PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.
NYSE Euronext

profile to come
Merck Serono International S.A

Merck Serono Ventures is the strategic, corporate venture capital fund of Merck Serono, a division of Merck KGaA, Darmstadt, Germany. The fund invests in biotech start-up companies that have the potential to provide novel products in Merck Serono's core therapeutic areas comprising Neurodegenerative Diseases, Oncology, Autoimmune & Inflammatory Diseases, Endocrinology and Fertility. In addition, Merck Serono Ventures invests in companies developing innovative platform technologies that could enable the discovery and development of new products in Merck Serono's core therapeutic areas. For more information visit www.merckserono.com
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance.
Thanks to our closely collaborating legal and tax practices, we have built up a unique and very solid position in the market. With about 1600 employees worldwide, consisting of about 400 tax experts and about the same number of legal experts, we are capable of effectively structuring and supervising both domestic and international matters. We provide services from our six Benelux offices and from our eleven branches based in the world's major financial centres.
Full Contact details:
Loyens & Loeff NV
Fred. Roeskestraat 100
1076 ED AMSTERDAM
Tel. +31 20 578 5785
Fax +31 20 578 58 00

Introduction
Lovells is one of the pre-eminent international leading law firms advising on contentious and non-contentious issues in the pharmaceutical, biosciences and medical devices industries. We advise clients on all matters relating to the full pharma / biotech product life cycle, from clinical trial agreements through to off patent strategy and from early stage financing to IPO or M&A consolidation. Life science is a core sector for the firm. Our group of dedicated industry specialists consists of 75 lawyers worldwide, many of whom are scientifically qualified. The team comprises experts in intellectual property, competition, product liability, regulatory, IT and dispute resolution. Lovells combines this expertise with a wide experience in the fields of equity capital markets, M&A and finance offering a full legal service for all our life sciences and venture capital clients.
The Amsterdam office comprises six practice areas:
* Corporate / M&A
Contact partners: Johannes Buntjer, Victor de Vlaam and Jan de Snaijer (civil law notary);
* Intellectual Property / Life Sciences
Contact partners: Klaas Bisschop, Bert Oosting and Marc Wallheimer;
* Banking & Finance, Business Restructuring & Capital Markets
Contact partner: Ken Breken;
* Tax
Contact partner: Anton Louwinger;
* Employment
Contact partner: Anita de Jong;
* Litigation & Arbitration
Contact partner: Klaas Bisschop.
Contact details:
Lovells LLP
Keizersgracht 555, 1017 DR Amsterdam
PO Box 545, 1000 AM Amsterdam
The Netherlands
T: +31 (0)20 55 33 600
F: +31 (0)20 55 33 777
www.lovells.com
|